02/24/2009
https://congress.gov...
"We want to look at the--we are talking about grant proposals."
"We cannot just accept your spin on it because people there may be self-interested, the people who funded the program."
"If you declassify it and you still hide it from the American people, that is a problem."
"price controls dull incentives for market entry and hamper drugmakers' ability to adopt conventional and effective market responses"